Corxel Pharmaceuticals Denmark ApS
CVR 45430324 · Private limited company (ApS) · Active · High risk
Corxel Pharmaceuticals Denmark ApS is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 6.5% over the next 12 months, which is 4.6 times the average for Danish companies. 1 annual report has been published. The latest annual report (31 Dec 2025) shows equity of DKK 40k and a net result of DKK 0. CEO: Roderick Wong, Yanping Mou.
Bankruptcy risk for Corxel Pharmaceuticals Denmark ApS
4.6 × the average (1.41%) · higher risk than 94% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45430324
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- c/o TMF Denmark A/S, H.C. Andersens Boulevard 38, 3. th
1553 København V - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 100.0% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 120 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK 0 |
| Net profit | DKK 0 |
| Equity | DKK 40k |
| Total assets | DKK 40k |
| Avg. employees | 0 |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 21 Feb 2025 – 31 Dec 2025 | 135 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Roderick Wong | Current | |
| CEO | Yanping Mou | Current | |
| Owner (100%) | Corxel Pharmaceuticals Hong Kong Limited | Current | |
| Founder | Corxel Pharmaceuticals Hong Kong Limited | Current |
Address history (0 moves)
| c/o TMF Denmark A/S, H.C. Andersens Boulevard 38, 3. th, 1553 København V |
Other companies at the same address
- ASX 11469 ApS Bankrupt
- ApS KBUS 38 NR. 1105 Bankrupt
- DAN-WOOD HOLDING A/S Bankrupt
- FÆLLESINVESTERINGEN AF 27. JULI 1982 ApS Bankrupt
- INVESTERINGSSELSKABET AF 20 JUNI 1988 ApS Bankrupt
- NEW BUSINESS TECHNOLOGY ApS Bankrupt
- PERMANENT SERVICE ApS Bankrupt
- SIXTUS MANAGEMENT GROUP ApS Bankrupt
- UJAC/JM 6 ApS Bankrupt
- AEW Kastrup ApS Active
- AICT EUR Real Estate (DS) GP ApS Active
- ALFA ENTREPRISE ApS Fusioneret
- ASP Danmark ApS Active
- ASX 11674 ApS Compulsorily dissolved
- ApS KBUS 38 NR. 1110 Compulsorily dissolved
- BAKER HUGHES DENMARK ApS Active
- BLUE CUBE DENMARK ApS Active
- Balyasny Asset Management (Europe) Fondsmæglerselskab A/S Active
- Balyasny Management (Denmark) ApS Active
- Berjaya Coffee Nordic ApS Active
- Berjaya Nordic (Denmark) ApS Active
- Bidco (Denmark) ApS Active
- Blue Yonder Denmark A/S Active
- BØRS-ApS 1 Compulsorily dissolved
- BØRS-ApS 2 Compulsorily dissolved
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
- Linker Pharmaceuticals ApS København K
Questions and answers about Corxel Pharmaceuticals Denmark ApS
Has Corxel Pharmaceuticals Denmark ApS gone bankrupt?
No, Corxel Pharmaceuticals Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Corxel Pharmaceuticals Denmark ApS?
Our model estimates a bankruptcy risk of 6.5% over the next 12 months (high risk), which is 4.6 times the average for Danish companies.
Who is the CEO of Corxel Pharmaceuticals Denmark ApS?
Roderick Wong, Yanping Mou are the CEOs of Corxel Pharmaceuticals Denmark ApS.
When was Corxel Pharmaceuticals Denmark ApS founded?
Corxel Pharmaceuticals Denmark ApS was founded on 21 February 2025.
What is the equity of Corxel Pharmaceuticals Denmark ApS?
Equity was DKK 40k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.